Ana P Lourenco, MD | |
593 Eddy St, Providence, RI 02903-4923 | |
(401) 444-5184 | |
Not Available |
Full Name | Ana P Lourenco |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 22 Years |
Location | 593 Eddy St, Providence, Rhode Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336203561 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 230767 (Massachusetts) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | MD12576 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Rhode Island Hospital | Providence, RI | Hospital |
Women & Infants Hospital Of Rhode Island | Providence, RI | Hospital |
The Miriam Hospital | Providence, RI | Hospital |
Kent County Memorial Hospital | Warwick, RI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rhode Island Medical Imaging | 8022097815 | 108 |
News Archive
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.
Minerva Biotechnologies, a leading cancer and stem cell development company today announced a major breakthrough in human stem cell research.
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
Ben-Gurion University of the Negev researchers have found that the age puberty hits is based on the gap between the parents' and child's ultimate height, not genetics.
› Verified 5 days ago
Entity Name | Rhode Island Medical Imaging |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205874930 PECOS PAC ID: 8022097815 Enrollment ID: O20040715000832 |
News Archive
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.
Minerva Biotechnologies, a leading cancer and stem cell development company today announced a major breakthrough in human stem cell research.
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
Ben-Gurion University of the Negev researchers have found that the age puberty hits is based on the gap between the parents' and child's ultimate height, not genetics.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ana P Lourenco, MD 125 Metro Center Blvd Ste 2000, Warwick, RI 02886-1785 Ph: (401) 432-2520 | Ana P Lourenco, MD 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 444-5184 |
News Archive
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.
Minerva Biotechnologies, a leading cancer and stem cell development company today announced a major breakthrough in human stem cell research.
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
Ben-Gurion University of the Negev researchers have found that the age puberty hits is based on the gap between the parents' and child's ultimate height, not genetics.
› Verified 5 days ago
Lars Stangenberg, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2 Dudley St, Suite 470, Providence, RI 02905 Phone: 401-553-8318 Fax: 401-868-2307 | |
Kara Lynne Leonard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Rih Radiation Oncology, Providence, RI 02903 Phone: 401-444-8311 Fax: 401-444-5335 | |
Michael Low Cardenas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 825 N Main St, Providence, RI 02904 Phone: 774-279-0884 | |
Earle O Assanah, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5174 | |
Sarah-kim Shields, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Radiology, Providence, RI 02903 Phone: 401-444-2133 Fax: 401-444-5017 | |
Sean O'neill, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5127 Fax: 401-444-3056 | |
John Scaringi, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4000 |